SCHEMBL21323228

SCHEMBL21323228

O=C(/C=C/c1ccc(OC(F)(F)F)cc1)N1CC2CN(C(=O)N3CCc4[nH]nnc4C3)CC2C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ ENPP2 Q13822 2/20 0.40
▸ ATXN2 Q99700 2/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CCR2 P41597 1/20 0.38
▸ STAT3 P40763 1/20 0.36
▸ MCHR1 Q99705 4/20 0.35
▸ GPR183 P32249 2/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962008 1.00 HRH3 (0.41) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16962012 1.00 HRH3 (0.41) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16963644 1.00 HRH3 (0.41) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16963647 1.00 HRH3 (0.41) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16963160 0.94 CCR2 (0.42) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL21323305 0.94 CCR2 (0.42) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16963155 0.94 CCR2 (0.42) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL16963645 0.84 HRH3 (0.39) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL21313909 0.84 HRH3 (0.39) HRH3NAMPTENPP2ATXN2CYP2D6
SCHEMBL21313880 0.84 HRH3 (0.39) HRH3NAMPTENPP2ATXN2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback